Systems for providing fluid flow to tissues
View Patent ↗Provided is an apparatus that includes a scaffold with a gel or liquid composition deposed on at least a portion of a luminal surface, the gel or liquid composition adapted to include microbubbles. Also provided is a system that includes a source of reduced pressure, the above scaffold, a manifold adjacent the scaffold, and a conduit for providing fluid communication between the manifold and the source of reduced pressure. Additionally provided is a method that includes implanting the above scaffold at the tissue site and disrupting a substantial portion of the microbubbles to induce fluid flow to the scaffold. Further provided is an apparatus that includes a scaffold that comprises a slowly degradable material and a quickly degradable material. Additionally provided is a system for coupling nerve tissue and a microchip assembly.
1. An apparatus for providing reduced pressure to a wound that is a gap in the diaphysis of a bone and facilitating growth of tissue within the wound, the apparatus comprising:
a scaffold for implantation in the gap, the scaffold providing a tubular structure for the growth of the tissue and having a channel extending axially through the scaffold, so that if the scaffold is implanted within the gap, the channel is in direct fluid communication with an intramedullary space of the bone;
a chemical substance coating at least a portion of a luminal surface of the channel and having a composition adaptable to contain microbubbles; and
a manifold having a plurality of interconnected flow channels for providing the reduced pressure to the scaffold.
2. The apparatus of claim 1 , wherein the chemical substance is pre-formed with the microbubbles.
3. The apparatus of claim 1 , wherein the chemical substance is operable to form microbubbles in response to a stimulus inducing a gaseous phase transition in the chemical substance.
4. The apparatus of claim 1 , wherein the scaffold is a substantially cylindrical shape having a plurality of channels in fluid communication with the wound, a portion of the channels at least partially covered with the chemical substance.
5. The apparatus of claim 1 , wherein the chemical substance comprises a perfluorocarbon.
6. The apparatus of claim 5 , wherein the perfluorocarbon is one of a perfluoropentane (C 5 F 12 ) or decafluorobutane (C 4 F 10 ).
7. The apparatus of claim 1 , wherein the chemical substance further comprises an amphiphilic substance.
8. The apparatus of claim 7 , wherein the amphiphilic substance is a block copolymer.
9. The apparatus of claim 8 , wherein the block copolymer is (poly(ethylene oxide)-block-poly(L-lactide)) (PEG-PLLA), poly(ethylene oxide)-block-poly(caprolactone)), or Pluronic P-105.
10. The apparatus of claim 1 , wherein the chemical substance further comprises a bioactive agent.
11. The apparatus of claim 10 , wherein the bioactive agent is at least one of an antibiotic and a growth factor.
12. The apparatus of claim 10 , wherein the bioactive agent is growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF).
13. A system for providing reduced pressure to a wound that is a gap in the diaphysis of the bone and facilitating growth of tissue within the wound, the system comprising:
a pressure source for supplying the reduced pressure;
a manifold having a plurality of interconnected flow channels in fluid communication with the pressure source for providing the reduced pressure to the tissue site;
a scaffold for implantation in the gap and in fluid communication with the manifold for delivering the reduced pressure to the wound, the scaffold having a cylindrical structure to support the growth of tissue and the scaffold having at least one channel extending axially through the structure, so that if the scaffold is implanted within the gap, the channel is in direct fluid communication with an intramedullary space of the bone and adapted for fluid communication with the wound, the channel having a luminal surface; and
a chemical substance coating at least a portion of the luminal surface and containing microbubbles adaptable to facilitate a flow of fluid from the wound through the at least one channel within the scaffold.
14. The system of claim 13 , wherein the chemical substance is pre-formed with the microbubbles.
15. The system of claim 13 , wherein the chemical substance is operable to form microbubbles in response to a stimulus inducing a gaseous phase transition in the chemical substance.
16. The system of claim 13 , wherein said scaffold is a substantially tubular shape having one channel in fluid communication with the wound.
17. The system of claim 13 , wherein said scaffold is a substantially cylindrical shape having a plurality of channels in fluid communication with the wound, a portion of the channels having a luminal surface at least partially covered with said chemical substance.
18. The system of claim 13 , wherein the chemical substance comprises a perfluorocarbon.
19. The system of claim 18 , wherein the perfluorocarbon is one of a perfluoropentane (C 5 F 12 ) or decafluorobutane (C 4 F 10 ).
20. The system of claim 13 , wherein the chemical substance further comprises an amphiphilic substance.
21. The system of claim 20 , wherein the amphiphilic substance is a block copolymer.
22. The system of claim 21 , wherein the block copolymer is (poly(ethylene oxide)-block-poly(L-lactide)) (PEG-PLLA), poly(ethylene oxide)-block-poly(caprolactone)), or Pluronic P-105.
23. The system of claim 13 , wherein the chemical substance further comprises a bioactive agent.
24. The system of claim 23 , wherein the bioactive agent is at least one of an antibiotic and a growth factor.
25. The system of claim 23 , wherein the bioactive agent is growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α), or nerve growth factor (NGF).
26. The system of claim 13 , wherein said scaffold has reduced pressure chambers.
27. A method for providing reduced pressure to a wound that is a gap in the diaphysis of a bone and facilitating growth of tissue within the wound, the method comprising:
utilizing a scaffold having at least one channel within the structure in fluid communication with the wound wherein a luminal surface of the channel is at least partially coated by a chemical substance containing microbubbles, and the channel is in direct fluid communication with an intramedullary space of the bone;
implanting the scaffold in the gap for providing a structure for the growth of the tissue and providing the reduced pressure to the tissue site;
applying reduced pressure to the scaffold and the wound; and
disrupting a substantial portion of the microbubbles to induce a flow of fluids within the scaffold, thereby facilitating the growth of tissue within the wound.